Hamburg, Germany
Amacuro GmbH, founded in 2022 and headquartered in Germany, is redefining the landscape of homecare processes with a unique approach summarized in their slogan: "Amacuro denkt, definiert und lebt die klassischen Homecare–Prozesse neu.”
The company's mission is to enhance patient quality of life and optimize therapy outcomes by combining pharmaceutical production, specialized therapeutic services, and personalized patient care. They strategically support healthcare providers, including care homes, clinics, and physicians, enabling them to focus more on resident and patient engagement.
With no recorded external investments yet, Amacuro GmbH offers a compelling prospect for investors looking to enter the integrated healthcare services sector, backed by their commitment to pharmaceutical, therapeutic, and medical excellence throughout the care continuum. This innovative holistic model positions Amacuro GmbH as a potential disruptor in the healthcare industry, poised for growth.
